/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · DE · FY ends Dec · -$110M FCF
$25.73
+$1.30 (+5.32%)
EOD Sep 18, 2026
ROIC dropped from -29.39% to -34.14%, capital efficiency is deteriorating. Negative free cash flow of -$95M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$149M
▼ -38.7% YoY
Op. Margin
—
ROIC
-38.89%
▼ -4.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$110M
▼ -35.3% YoY
Op. Cash Flow (TTM)
-$110M
▼ -36.4% YoY
Net Debt
-$68M
Net Cash Position
Cash & Equiv.
$74M
Continue Research
SourceComputed from the 10-Q filed 4 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 5 Aug 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.